Trial Outcomes & Findings for Influence of Fibrin Glue on Seroma Formation After Modified Radical Mastectomy (NCT NCT00909649)
NCT ID: NCT00909649
Last Updated: 2009-05-28
Results Overview
the mean total drainage volume
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
50 participants
Primary outcome timeframe
within 30 days postoperative
Results posted on
2009-05-28
Participant Flow
medical clinic
Participant milestones
| Measure |
Fibrin Group
|
Non Fibrin Group
|
|---|---|---|
|
Overall Study
STARTED
|
25
|
25
|
|
Overall Study
COMPLETED
|
25
|
25
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Influence of Fibrin Glue on Seroma Formation After Modified Radical Mastectomy
Baseline characteristics by cohort
| Measure |
Fibrin Group
n=25 Participants
|
Non Fibrin Group
n=25 Participants
|
Total
n=50 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0.0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
22 Participants
n=5 Participants
|
22 Participants
n=7 Participants
|
44.0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
3 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
6.0 Participants
n=5 Participants
|
|
Age Continuous
|
52.2 years
STANDARD_DEVIATION 11.5 • n=5 Participants
|
51.6 years
STANDARD_DEVIATION 10.8 • n=7 Participants
|
51.9 years
STANDARD_DEVIATION 10.7 • n=5 Participants
|
|
Sex: Female, Male
Female
|
25 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
50.0 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0.0 Participants
n=5 Participants
|
|
Region of Enrollment
Egypt
|
25 participants
n=5 Participants
|
25 participants
n=7 Participants
|
50.0 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: within 30 days postoperativePopulation: ITT
the mean total drainage volume
Outcome measures
| Measure |
Fibrin Group
n=25 Participants
|
Non Fibrin Group
n=25 Participants
|
|---|---|---|
|
Seroma Formation
|
770.48 ml
Standard Deviation 70.81
|
1089.51 ml
Standard Deviation 75.8
|
Adverse Events
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place